Align Technology Inc. (ALGN)$163.61

Market Cap: 13.00 BCurrency: USD

Research Snapshot

Static fundamentals, valuation context, and investor signals for Align Technology Inc. (ALGN).

HEALTHCARE

MEDICAL INSTRUMENTS & SUPPLIES

DCF ready

Valuation

24.3x

EV/FCF, 4.1% FCF yield

Quality

10.1%

ROIC, 12.2% FCF margin

Growth

10.3%

5Y sales (revenue) CAGR

Balance sheet

0.0x

Debt/equity, 1.4x current ratio

Superinvestors

Top: Ruane Cunniff (3.4%)

Strengths to research

Revenue compounded at 10.3% over five years.
Free cash flow margin is healthy at 12.2%.
Debt/equity looks manageable at 0.0x.
10 annual periods are available for trend analysis.

Watchouts

No major valuation, balance sheet, or growth watchouts were detected by the static screen.

Annual data: 10 periods

Quarterly data: 24 periods

Stock snapshot: May 25, 2026

Static dataset: May 25, 2026

Quality Scorecard

Build-time composite score for ALGN.

Grade B

/ 100

Peer Comparison

Target stock against 8 market-cap comparable peers.

Heat map: red worst to green best


ALGN Target	Align Technology Inc.	$13.0B	29.0x	24.3x	10.1%	10.3%	12.2%	67.2%	-1.4x	N/A
HOLX	Hologic Inc.	$11.8B	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SOLV	Solventum Corp	$11.6B	8.7x	-1572.9x	15.4%	N/A	-0.1%	53.5%	1.6x	N/A
BAX	Baxter International Inc.	$15.6B	-10.3x	69.5x	-6.1%	-0.7%	3.0%	30.1%	11.1x	N/A
COO	Cooper Cos Inc	$16.3B	33.4x	37.4x	4.6%	11.0%	10.6%	65.5%	-0.1x	N/A
AVTR	Avantor arinc.	$8.6B	-10.4x	24.6x	-5.6%	0.5%	7.6%	32.7%	N/A	N/A
RGEN	Repligen Corp.	$7.9B	133.8x	84.1x	1.8%	N/A	N/A	N/A	-0.3x	N/A
TFX	TELEFLEX INCORPORATED	$5.5B	-6.6x	5362.4x	-15.7%	-4.7%	0.1%	56.2%	13.0x	N/A
RMD	ResMed Inc.	$35.3B	21.9x	20.9x	21.1%	11.7%	32.3%	59.4%	-0.3x	N/A

Financial Charts

No financial data available for ALGN (annual).

1 superinvestors own ALGN

Current quarter ownership and quarter-over-quarter share changes.

Superinvestor ownership

Fund	Shares	Value	% Portfolio	QoQ Change
Ruane Cunniff Sequoia Fund	1,206,535	$207M	3.43%	0.0%